Amiodarone in cardiac transplant waiting list patients with severe heart failure
Heart transplantation is the «gold standard» of severe heart failure treatment. Sudden arrhythmic death is the leading cause of death among these patients. Amiodarone is the only antiarrhythmic drug with beneficial effect on survival of patients with end-stage heart failure. Given its long half-life...
Saved in:
| Main Authors: | N. N. Koloskova, V. N. Poptsov, G. M. Salikhova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2017-06-01
|
| Series: | Вестник трансплантологии и искусственных органов |
| Subjects: | |
| Online Access: | https://journal.transpl.ru/vtio/article/view/761 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE INDIVIDUAL TAILORING OF IMMUNOSUPPRESSIVE THERAPY AFTER HEART TRANSPLANTATION
by: N. N. Koloskova, et al.
Published: (2018-04-01) -
Heart transplantation for primary cardiac sarcoma
by: A. Yu. Goncharova, et al.
Published: (2022-09-01) -
Survival analysis of patients in the waiting list for kidney transplantation in terms of competing risks
by: A. V. Vatazin, et al.
Published: (2019-05-01) -
A single center experience of concomitant administration of sofosbuvir/velpatasvir and amiodarone after heart and lung transplantation
by: Ryan M. Rivosecchi, et al.
Published: (2025-08-01) -
Amiodarone use and prolonged mechanical ventilation after cardiac surgery: a single-center analysis
by: Xin Li, et al.
Published: (2025-02-01)